We are live on
!
Find out more
JCM
JS Capital Management Portfolio holdings
AUM
$109M
1-Year Est. Return
34.13%
This Fund
S&P 500
This Quarter
Est. Return
-10.95%
1 Year Est. Return
-34.13%
3 Year Est. Return
-16.34%
5 Year Est. Return
-37.7%
10 Year Est. Return
+464.39%
AUM
$795M
AUM Growth
-$73.2M
(-8.4%)
Cap. Flow
+$67.5M
Cap. Flow
% of AUM
8.49%
Top 10 Holdings %
Top 10 Hldgs %
77.27%
Holding
222
New
103
Increased
11
Reduced
9
Closed
97
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
O'Reilly Automotive
ORLY
|
+$40.3M |
| 2 |
Amazon
AMZN
|
+$32.9M |
| 3 |
Fidelity National Information Services
FIS
|
+$32.3M |
| 4 |
Microsoft
MSFT
|
+$28M |
| 5 |
Booking.com
BKNG
|
+$24.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
10x Genomics
TXG
|
+$20.4M |
| 2 |
DAY
Dayforce
DAY
|
+$16.3M |
| 3 |
VICI Properties
VICI
|
+$16M |
| 4 |
FSCT
ForeScout Technologies, Inc. Common Stock
FSCT
|
+$15.6M |
| 5 |
Equifax
EFX
|
+$15.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 45.66% |
| 2 | Technology | 22.86% |
| 3 | Healthcare | 12.16% |
| 4 | Communication Services | 12.05% |
| 5 | Real Estate | 2.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Boston Scientific
BSX
$69.5B
| $431K | 0.05% |
+13,200
| New | +$516K |
|
52
CDW
CDW
$18.9B
| $429K | 0.05% |
+4,600
| New | +$563K |
|
|
FG
53
DELISTED
FGL Holdings Ordinary Shares
FG
| $428K | 0.05% |
+43,700
| New | +$462K |
|
54
AutoZone
AZO
$49.2B
| $423K | 0.05% |
+500
| New | +$520K |
|
|
RETA
55
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $419K | 0.05% |
+2,900
| New | +$560K |
|
56
Open Text
OTEX
$6.15B
| $416K | 0.05% |
+11,900
| New | +$504K |
|
57
KKR & Co
KKR
$91.1B
| $411K | 0.05% |
+17,500
| New | +$503K |
|
58
Apollo Global Management
APO
$72.4B
| $402K | 0.05% |
+12,000
| New | +$515K |
|
59
TTM Technologies
TTMI
$12B
| $398K | 0.05% |
38,500
-4,200
| -10% | -$55.2K |
|
60
NewMarket
NEU
$7.82B
| $383K | 0.05% |
+1,000
| New | +$422K |
|
61
ResMed
RMD
$30.6B
| $368K | 0.05% |
+2,500
| New | +$398K |
|
62
Levi Strauss
LEVI
$9.44B
| $365K | 0.05% |
+29,400
| New | +$520K |
|
63
Burlington
BURL
$23.2B
| $364K | 0.05% |
+2,300
| New | +$484K |
|
64
Eldorado Gold
EGO
$7.87B
| $355K | 0.04% |
+57,500
| New | +$433K |
|
65
TJX Companies
TJX
$174B
| $354K | 0.04% |
+7,400
| New | +$426K |
|
66
Hecla Mining
HL
$9.47B
| $345K | 0.04% |
+189,400
| New | +$524K |
|
67
BILL Holdings
BILL
$4.49B
| $342K | 0.04% |
10,000
-40,000
| -80% | -$1.89M |
|
68
Community Health Systems
CYH
$393M
| $339K | 0.04% |
+101,400
| New | +$411K |
|
|
ENDP
69
DELISTED
Endo International plc
ENDP
| $335K | 0.04% |
+90,600
| New | +$459K |
|
70
MasTec
MTZ
$21.1B
| $334K | 0.04% |
+10,200
| New | +$519K |
|
71
RPM International
RPM
$13.7B
| $327K | 0.04% |
+5,500
| New | +$379K |
|
72
Chubb
CB
$135B
| $324K | 0.04% |
+2,900
| New | +$416K |
|
73
Asbury Automotive
ABG
$4.31B
| $309K | 0.04% |
+5,600
| New | +$488K |
|
74
Churchill Downs
CHDN
$5.88B
| $309K | 0.04% |
+6,000
| New | +$387K |
|
|
SNV
75
DELISTED
Synovus
SNV
| $302K | 0.04% |
+17,200
| New | +$530K |
|
Similar funds
SC
WP
CFM
PL
PC
KWM
PCMN
BOTPPF
JS Capital Management's Q1 2020 Portfolio in Review
As of Q1 2020, JS Capital Management held 222 positions worth $795M, down 8.4% from $868M the previous quarter. Its ten largest holdings account for 77% of the portfolio.
JS Capital Management deployed $67.5M of net new capital in Q1 2020, opening 103 new positions and adding to 11 existing holdings. Its largest new stake was O'Reilly Automotive: 1,578,000 shares worth $31.7M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 46% of assets, up from 41% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was 10x Genomics, an estimated $20.4M trimmed.
- JS Capital Management's largest Q1 2020 buy was O'Reilly Automotive: 1,578,000 shares worth $31.7M.
- JS Capital Management added most to Amazon in Q1 2020, an estimated $32.9M increase.
- JS Capital Management's biggest Q1 2020 reduction was 10x Genomics, cutting an estimated $20.4M.
- JS Capital Management fully exited Dayforce in Q1 2020, selling an estimated $16.3M.
- JS Capital Management's ten largest holdings make up 77% of its $795M portfolio in Q1 2020.
- JS Capital Management opened 103 new positions and closed 97 in Q1 2020.
- JS Capital Management's portfolio value fell 8.4% quarter-over-quarter to $795M.
Based on JS Capital Management's 13F filing for Q1 2020, filed 15 May 2020.